Journey Medical Corporation Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2025


	Three Months Ended March 31,
($ in thousands)	2025		2024
Revenue	$	13,139	$	13,030
Less: Segment Expenses⁽¹⁾
Cost of goods sold – (excluding amortization of acquired intangible assets)		4,790		6,002
Research and development		39		7,884
Selling, general and administrative
Employee related		4,031		3,701
Sales, operations, outside services and consulting		3,078		1,941
Marketing related		1,057		352
Stock compensation		1,323		1,261
Legal and administrative		513		440
Product compliance expense		275		411
Office and administrative		226		187
Other		66		125
Other segment items⁽²⁾		1,814		1,168
Segment expenses		17,212		23,472
Net loss	$	(4,073)	$	(10,442)

Reconciliation of net loss:
Adjustments and reconciling items		—		—
Net loss	$	(4,073)	$	(10,442)

(1)The significant expense amounts align with the expenses that the CODM is regularly provided with to assess performance and allocate resources.

(2)

Other segment items for the reportable segment include amortization of intangible assets, interest income (expense), foreign exchange transaction losses and income tax expense.